American Cryostem logo

CRYO - American Cryostem Share Price

$0.45 0.0  4.7%

Last Trade - 13/09/19

Sector
Healthcare
Size
Micro Cap
Market Cap £17.8m
Enterprise Value £18.3m
Revenue £255k
Position in Universe 5188th / 6399
Bullish
Bearish
Unlock CRYO Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CRYO Revenue Unlock CRYO Revenue

Net Income

CRYO Net Income Unlock CRYO Revenue

Normalised EPS

CRYO Normalised EPS Unlock CRYO Revenue

PE Ratio Range

CRYO PE Ratio Range Unlock CRYO Revenue

Dividend Yield Range

CRYO Dividend Yield Range Unlock CRYO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CRYO EPS Forecasts Unlock CRYO Revenue
Profile Summary

American CryoStem Corporation is a developer and marketer of adipose tissue-based cellular technologies and related services. The Company focuses on clinical processing, commercial bio-banking and application development for adipose (fat) tissue and autologous adipose-derived regenerative cells (ADRCs). The Company's products and services include CELLECT, ATGRAFT, ATCELL, ACSelerate, ACS Laboratories, Autokine-CM and International Licensing Program. The Company is in the business of collecting adipose tissue, processing it to separate the adult stem cells, and preparing such stem cells for long-term storage. Its ATGRAFT procedures include breast reconstruction, layered augmentation, buttocks enhancement or volume corrections of the hands, feet, face and neck areas. Its ACSelerate product is engaged in manufacturing various versions of its ACSelerate cell culture media, which includes ACSelerate-MAX, ACSelerate-SFM, ACSelerate-CY, ACSelerate-MY, ACSelerate-CP and ACSelerate-TR.

Directors
Last Annual September 30th, 2018
Last Interim June 30th, 2019
Incorporated March 13, 2009
No. of Shareholders: 162
No. of Employees: 6
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OTC Markets Group
Shares in Issue 49,337,918
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CRYO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to CRYO
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.